Hypoallergenic molecules for subcutaneous immunotherapy

TY - JOUR

T1 - Hypoallergenic molecules for subcutaneous immunotherapy

AU - Jongejan, Laurian

AU - van Ree, Ronald

AU - Poulsen, Lars K

PY - 2016/1/2

Y1 - 2016/1/2

N2 - Although a large part of the population suffers from allergies, a cure is not yet available. Allergen-specific immunotherapy (AIT) offers promise for these patients. AIT has proven successful in insect and venom allergies; however, for food allergy this is still unclear. In this editorial we focus on the recent advances in a proof of concept study in food allergy, FAST (Food allergy specific immunotherapy), which may increase interest within the biomolecular and pharmaceutical industry to embark on similar projects of immunology driven precision medicine within the allergy field.

AB - Although a large part of the population suffers from allergies, a cure is not yet available. Allergen-specific immunotherapy (AIT) offers promise for these patients. AIT has proven successful in insect and venom allergies; however, for food allergy this is still unclear. In this editorial we focus on the recent advances in a proof of concept study in food allergy, FAST (Food allergy specific immunotherapy), which may increase interest within the biomolecular and pharmaceutical industry to embark on similar projects of immunology driven precision medicine within the allergy field.

KW - Allergens

KW - Animals

KW - Desensitization, Immunologic

KW - Fish Proteins

KW - Food

KW - Humans

KW - Hypersensitivity

KW - Injections, Subcutaneous

KW - Venoms

KW - Editorial

KW - Review

U2 - 10.1586/1744666x.2016.1103182

DO - 10.1586/1744666x.2016.1103182

M3 - Editorial

C2 - 26558320

SN - 1744-666X

VL - 12

SP - 5

EP - 7

JO - Expert Review of Clinical Immunology

JF - Expert Review of Clinical Immunology

IS - 1

ER -